BRIGHT MINDS BIOSCIENCES INC. - Common Shares (DRUG)

Historical Holders from Q3 2023 to Q4 2024

Symbol
DRUG on Nasdaq
CUSIP
10919W405
Type / Class
Equity / Common Shares
Shares outstanding
7.04M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
4.9M
Holdings value
$176M
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
30
Number of buys
24
Number of sells
-3
Average Value change %
+0%
Average buys %
+0.002%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BRIGHT MINDS BIOSCIENCES INC. - Common Shares (DRUG)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 16% +36.7% $40.6M $11.2M 1.11M +38.1% JANUS HENDERSON GROUP PLC Mar 31, 2025
Sio Capital Management, LLC 7.21% +10.1% $18.5M $2.04M 508K +12.3% Sio Capital Management, LLC Mar 31, 2025
COMMODORE CAPITAL LP 7.2% $18.3M 500K COMMODORE CAPITAL LP Dec 31, 2024
Point72 Asset Management, L.P. 3% $4.93M 135K Point72 Asset Management, L.P. Dec 31, 2024

Institutional Holders of BRIGHT MINDS BIOSCIENCES INC. - Common Shares (DRUG)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 4.9M $176M +$167M $36.02 30
2024 Q3 192K $230K -$6.16K $1.17 6
2024 Q2 197K $207K -$19.3K $1.05 5
2024 Q1 213K $256K -$27.2K $1.20 7
2023 Q4 228K $330K +$48.2K $1.43 6
2023 Q3 195K $309K +$309K $1.60 5